… Wednesday, Thoratec Laboratories' THOR key competitor in chronic ventricular assist devices, or VADs, HeartWare International HTWR , received the endorsement of a Food and Drug Administration review panel in a 9-2 vote for its device …
WASHINGTON, April 25 (Reuters) - HeartWare International Inc won a U.S. advisory panel's support on Wednesday for its most important product - a blood pump that helps people with severe heart failure.
April 25 (Reuters) - HeartWare International Inc won a U.S. advisory panel's support on Wednesday for its most important product: a blood pump that helps people with severe heart failure.
WASHINGTON (Reuters) - U.S. medical device reviewers said HeartWare International Inc's blood pump seemed to help people with severe heart failure but raised concerns about device-associated clotting...
WASHINGTON, April 23 (Reuters) - U.S. medical device reviewers said HeartWare International Inc's blood pump seemed to help people with severe heart failure but raised concerns about...
… reasons, including safety concerns or new entrants. HeartWare International is developing a new chronic VAD that could steal share ..... that surpass Thoratec's in the long run. In fact, HeartWare International aims to introduce a compelling new VAD that gives Thoratec …
Heartware ( HTWR -0.3% ) gets approval from the FDA to enroll 54 patients in a clinical trial of its "bridge" to a heart transplantation for …
HeartWare ( HTWR +1.9% ) moves higher after an FDA panel says it will review the Premarket Approval application for the company's Ventricular …
… Neutral from Buy on valuation. The firm says the stock may be played out over the near term, as peer competitor Heartware's ( HTWR +1% ) pending launch of HVAD is expected to cut into its heart therapy market share. Post your comment!
… unpredictable from quarter to quarter, given the uncertainty around penetration rates in destination therapy and HeartWare International 's ability to expand in U.S. and international markets in bridge-to-transplant and destination therapy …